Please login to the form below

Not currently logged in


This page shows the latest DAVID news and features for those working in and with pharma, biotech and healthcare.

Amgen’s Lumakras shows promise in phase 3 lung cancer study

Amgen’s Lumakras shows promise in phase 3 lung cancer study

David Reese, executive vice president of research and development at Amgen, said: "This data presented at ASCO underscores the clinical importance of Lumakras, including the only randomised trial of a KRAS

Latest news

More from news
Approximately 7 fully matching, plus 849 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 79 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 152 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 114 partially matching documents found.

Subscribe to our email news alerts


Add my company
Anthem PR

With a rare strength in media and influencer relations, Anthem’s award-winning team offers a fresh approach to health PR...

Latest intelligence

Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...